Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

TCA cycle inhibition by CPI-613 increases chemo sensitivity in older AML...

Dr Timothy Pardee - Wake Forest Baptist Medical Center, Winston-Salem, USA

TCA cycle inhibition by CPI-613 increases chemo sensitivity in older AML patients ( Dr Timothy Pardee - Wake Forest Baptist Medical Center, Winston-Salem, USA )

Azacitidine plus nivolumab against acute myeloid leukaemia

Prof Naval Daver - MD Anderson Cancer Center, Houston, USA

Azacitidine plus nivolumab against acute myeloid leukaemia ( Prof Naval Daver - MD Anderson Cancer Center, Houston, USA )

IKZF1 mutations associated with paediatric ALL

Dr Michelle Churchman - St. Jude Children's Research Hospital, Memphis, USA

IKZF1 mutations associated with paediatric ALL ( Dr Michelle Churchman - St. Jude Children's Research Hospital, Memphis, USA )

Rituximab after ASCT prolongs survival for young MCL patients

Prof Steven Le Gouill - Nantes Medical University, Nantes, France

Rituximab after ASCT prolongs survival for young MCL patients ( Prof Steven Le Gouill - Nantes Medical University, Nantes, France )

How can we use crenolanib to treat AML?

Dr Eunice Wang - Roswell Park Cancer Institute, New York, USA

How can we use crenolanib to treat AML? ( Dr Eunice Wang - Roswell Park Cancer Institute, New York, USA )

Highlights in myeloid leukaemia research from ASH 2016

Dr Luca Mazzarella - European Institute of Oncology, Milan, Italy

Highlights in myeloid leukaemia research from ASH 2016 ( Dr Luca Mazzarella - European Institute of Oncology, Milan, Italy )

Thromboembolytic risks of central venous catheters in paediatric patients

Dr Julie Jaffray - Children's Center for Cancer, Los Angeles, USA

Thromboembolytic risks of central venous catheters in paediatric patients ( Dr Julie Jaffray - Children's Center for Cancer, Los Angeles, USA )

Pure erythroid leukaemias

Dr Guillermo Montalbán Bravo - MD Anderson Cancer Center, Houston, USA

Pure erythroid leukaemias ( Dr Guillermo Montalbán Bravo - MD Anderson Cancer Center, Houston, USA )

Clinical updates for guadecitabine and vorinostat

Dr Guillermo Montalbán Bravo - MD Anderson Cancer Center, Houston, USA

Clinical updates for guadecitabine and vorinostat ( Dr Guillermo Montalbán Bravo - MD Anderson Cancer Center, Houston, USA )

ALL: Combining paediatric-type therapy with minimal residual disease

Dr Alessandro Rambaldi - Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy

ALL: Combining paediatric-type therapy with minimal residual disease ( Dr Alessandro Rambaldi - Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy )

Pracinostat and azacitidine for elderly AML

Prof Guillermo Garcia-Manero - MD Anderson Cancer Center, Houston, USA

Pracinostat and azacitidine for elderly AML ( Prof Guillermo Garcia-Manero - MD Anderson Cancer Center, Houston, USA )

ASH 2016: AML, CLL and leukaemogenesis latest

Dr Farhad Ravandi - MD Anderson Cancer Center, Houston, USA

ASH 2016: AML, CLL and leukaemogenesis latest ( Dr Farhad Ravandi - MD Anderson Cancer Center, Houston, USA )

More from ecancer